111 related articles for article (PubMed ID: 16626820)
1. Doppler echocardiography during the follow-up of hematological patients undergoing chemotherapy.
Marra F; Galderisi M; Camera A; Rinaldi CR; Innelli P; Rotoli B; de Divitiis O
Int J Cardiol; 2007 Jan; 114(3):403-4. PubMed ID: 16626820
[TBL] [Abstract][Full Text] [Related]
2. Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.
Galderisi M; Marra F; Esposito R; Lomoriello VS; Pardo M; de Divitiis O
Cardiovasc Ultrasound; 2007 Jan; 5():4. PubMed ID: 17254324
[TBL] [Abstract][Full Text] [Related]
3. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
Bosch X; Rovira M; Sitges M; Domènech A; Ortiz-Pérez JT; de Caralt TM; Morales-Ruiz M; Perea RJ; Monzó M; Esteve J
J Am Coll Cardiol; 2013 Jun; 61(23):2355-62. PubMed ID: 23583763
[TBL] [Abstract][Full Text] [Related]
4. Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors.
Shah C; Gong Y; Szady A; Sun Q; Pepine CJ; Langaee T; Lucas AR; Moreb JS
Cardiovasc Toxicol; 2018 Apr; 18(2):184-191. PubMed ID: 29022233
[TBL] [Abstract][Full Text] [Related]
5. Myocardial Strain Imaging by Echocardiography for the Prediction of Cardiotoxicity in Chemotherapy-Treated Patients: A Meta-Analysis.
Ye L; Yang ZG; Selvanayagam JB; Luo H; Yang TZ; Perry R; Diao KY; Huang S; Yang MX; Yang P; Jin Y; Guo YK
JACC Cardiovasc Imaging; 2020 Mar; 13(3):881-882. PubMed ID: 31734206
[No Abstract] [Full Text] [Related]
6. Cardiac involvement in patients with hematologic malignancies.
Allegra A; Alonci A; Russo S; Cannavò A; Penna G; D'Angelo A; Bellomo G; Musolino C
J Investig Med; 2010 Oct; 58(7):859-74. PubMed ID: 20683345
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy and the heart].
Plana JC
Rev Esp Cardiol; 2011 May; 64(5):409-15. PubMed ID: 21492985
[TBL] [Abstract][Full Text] [Related]
8. Drug-related cardiotoxicity for the treatment of haematological malignancies in elderly.
Malato A; Saccullo G; Fazio G; Vergara B; Raso S; Guarneri GP; Russo A; Abbadessa V; Siragusa S
Curr Pharm Des; 2010; 16(26):2872-9. PubMed ID: 20632949
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced cardiotoxicity: role of the conventional echocardiography and the tissue Doppler.
Di Lisi D; Bonura F; Macaione F; Cuttitta F; Peritore A; Meschisi M; Novo G; D'Alessandro N; Novo S
Minerva Cardioangiol; 2011 Aug; 59(4):301-8. PubMed ID: 21705993
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and Cardiotoxicity in Hematologic Malignancies.
Stellitano A; Fedele R; Barilla S; Iaria A; Rao CM; Martino M
Curr Cancer Drug Targets; 2017; 17(4):311-324. PubMed ID: 27903214
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline-induced cardiotoxicity in adult hematologic malignancies.
Johnson SA
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S22-7. PubMed ID: 16781286
[TBL] [Abstract][Full Text] [Related]
12. Cardio-oncology and echocardiography-partners in improving patient care.
Wiegers SE
J Am Soc Echocardiogr; 2015 Nov; 28(11):A15. PubMed ID: 26542336
[No Abstract] [Full Text] [Related]
13. [Value of pulsed Doppler tissue imaging for early detection of myocardial dysfunction with anthracyclines].
Tassan-Mangina S; Brasselet C; Nazeyrollas P; Collot-Bigot M; Costa B; Blaise AM; Laury P; Bonfils L; Metz D; Elaerts J
Arch Mal Coeur Vaiss; 2002 Apr; 95(4):263-8. PubMed ID: 12055764
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy-induced cardiac toxicity and management].
Komagata H; Sakai H
Gan To Kagaku Ryoho; 2003 Jun; 30(6):787-92. PubMed ID: 12852345
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of cardiotoxicity of high dose cyclophosphamide with electrocardiographic, echocardiographic, and troponin I monitoring in patients with breast tumors].
Benvenuto GM; La Vecchia L; Morandi P; Ruffini P; Mezzena G
Ital Heart J Suppl; 2000 Nov; 1(11):1457-63. PubMed ID: 11109196
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines.
Bossi G; Lanzarini L; Laudisa ML; Klersy C; Raisaro A; Aricò M
Med Pediatr Oncol; 2001 Jun; 36(6):593-600. PubMed ID: 11344489
[TBL] [Abstract][Full Text] [Related]
17. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
18. Amsacrine cardiotoxicity: assessment of ventricular function by radionuclide angiography.
Vorobiof DA; Iturralde M; Falkson G
Cancer Treat Rep; 1983 Dec; 67(12):1115-7. PubMed ID: 6689141
[TBL] [Abstract][Full Text] [Related]
19. Echocardiography and Doppler ultrasound in the evaluation of pericardial disease.
Chandraratna PA
Circulation; 1991 Sep; 84(3 Suppl):I303-10. PubMed ID: 1884500
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: a 5-year review at a single pediatric oncology center.
Watts RG; George M; Johnson WH
Cancer; 2012 Apr; 118(7):1919-24. PubMed ID: 21882180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
